Chapter/Section Purchase

1 Study Coverage
1.1 Herpes Simplex Virus (HSV) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region
2.4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Herpes Simplex Virus (HSV) Vaccines by Region (2023-2028)
2.5 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region
2.5.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2022)
2.5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturers
3.1.1 Global Top Herpes Simplex Virus (HSV) Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Simplex Virus (HSV) Vaccines in 2021
3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers
3.2.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Herpes Simplex Virus (HSV) Vaccines Revenue in 2021
3.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Herpes Simplex Virus (HSV) Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Type
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type
4.2.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type
4.3.1 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2017-2022)
4.3.2 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales by Application
5.1.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application
5.2.1 Global Herpes Simplex Virus (HSV) Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Herpes Simplex Virus (HSV) Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application
5.3.1 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2017-2022)
5.3.2 Global Herpes Simplex Virus (HSV) Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Type
6.1.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
6.1.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
6.2 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Application
6.2.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
6.2.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
6.3 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
6.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
6.3.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Type
7.1.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
7.1.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
7.2 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Application
7.2.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
7.2.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
7.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country
7.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
7.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Type
8.1.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Application
8.2.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Region
8.3.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Type
9.1.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
9.2 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Application
9.2.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
9.3 Latin America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
9.3.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Type
10.1.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Application
10.2.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country
10.3.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
11.3 Genocea Biosciences
11.3.1 Genocea Biosciences Corporation Information
11.3.2 Genocea Biosciences Overview
11.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Genocea Biosciences Recent Developments
11.4 Vical
11.4.1 Vical Corporation Information
11.4.2 Vical Overview
11.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Vical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herpes Simplex Virus (HSV) Vaccines Industry Chain Analysis
12.2 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herpes Simplex Virus (HSV) Vaccines Production Mode & Process
12.4 Herpes Simplex Virus (HSV) Vaccines Sales and Marketing
12.4.1 Herpes Simplex Virus (HSV) Vaccines Sales Channels
12.4.2 Herpes Simplex Virus (HSV) Vaccines Distributors
12.5 Herpes Simplex Virus (HSV) Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Herpes Simplex Virus (HSV) Vaccines Industry Trends
13.2 Herpes Simplex Virus (HSV) Vaccines Market Drivers
13.3 Herpes Simplex Virus (HSV) Vaccines Market Challenges
13.4 Herpes Simplex Virus (HSV) Vaccines Market Restraints
14 Key Findings in The Global Herpes Simplex Virus (HSV) Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer